Skip to Content

Vaccinia Approval History

  • FDA approved: Yes (First approved May 2nd, 2005)
  • Brand name: Vaccinia
  • Generic name: vaccinia immune globulin intravenous (human)
  • Dosage form: Injection
  • Company: DynPort Vaccine Company LLC
  • Treatment for: Smallpox Vaccine Reaction

Vaccinia Immune Globulin Intravenous (Human) (VIGIV) indicated for the treatment of complications from smallpox vaccination

Development History and FDA Approval Process for Vaccinia

Feb 18, 2005Approval Vaccinia DynPort Vaccine Company LLC - Treatment for Complications of Smallpox Vaccination
Aug  3, 2004DVC Announces FDA Acceptance for Filing of Vaccinia Immune Globulin BLA

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.